Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydrochlorothiazide for blood pressure lowering in adults with moderate-to-severe chronic kidney disease
TCTR20261012002Phase 4Not yet recruiting
- Sponsor
- Hatyai Hospital
- Start
- Jan 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of hydrochlorothiazide in hypertension (HTN), chronic kidney disease (CKD), sponsored by Hatyai Hospital. Planned start Jan 2027; status: not yet recruiting.
02
Drugs
hydrochlorothiazide
03
Conditions
hypertension (HTN)chronic kidney disease (CKD)
Beyond the preview
Go deeper on TCTR20261012002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20261012002.